ASSOCIATE PROF. DR. ROZITA BINTI ABDUL MALIK
Department of Oncology Clinical
Faculty of Medicine
rozita_abdulmalikum.edu.myPublication
Finance
Amivantamab plus FOLFOX or FOLFIRI in <i>RAS/BRAF</i> wild-type metastatic colorectal cancer: Long-term follow-up from the phase 1b/2 OrigAMI-1 study.
<i>FGFR2</i> Fusions or Rearrangements in Young Intrahepatic and Perihilar Cholangiocarcinoma Patients: Key Genetic Insights From a Pan-Asian Study
Prospective Genomic Profiling Study in Sarcoma Patients
Amivantamab with or without chemotherapy in right-sided metastatic colorectal cancer: Updated results from OrigAMI-1, an open-label, phase 1b/2 study.
Preliminary experience on the implementation of computed tomography (CT)-based image guided brachytherapy (IGBT) of cervical cancer using high-dose-rate (HDR) Cobalt-60 source in University of Malaya Medical Centre (UMMC)
Metformin synergizes 5-fluorouracil, epirubicin, and cyclophosphamide (FEC) sensitivity in breast cancer stem cells and non-stem breast cancer cells.
CT-based 3D Treatment Planning of Co-60 HDR Intracavitary Brachytherapy: A Comparison Between Volumetric and ICRU Point of Rectum and Bladder Doses.
